Signal Selection & Filters
Observed Relative Risk (RR)
1.02
1.0 = Exact null effect / no increased risk
95% CI Lower Bound
0.95
95% CI Upper Bound
1.09
Total Sample Size (N)
1,250,000
Peer-Reviewed Controlled Studies
42
VAERS / Spontaneous Reports
1,420
Signal Verification Metrics Validated Safe
Signal Strength Score
1.4
0.0 (Null) - 10.0 (High)
Statistical Significance
Not Significant (Null Effect)
p = 0.62 (95% CI includes 1.0)
Risk of Bias Rating
Low (Large-Scale Controlled Studies)
GRADE Methodology
Consensus Status
Overwhelming Epidemiological Consensus
Global Health Bodies
D3.js Evidence Matrix: Sample Size vs Relative Risk (with 95% CI)
Side-by-Side Signal Ledger: Claim vs Empirical Cohort
| Evidence Dimension | Spontaneous Unverified Claims | Controlled Peer-Reviewed Studies | Statistical Variance |
|---|---|---|---|
| Cohort Scale | 1,420 unverified event submissions | 1,250,000 verified patients across 42 trials | 880x higher statistical power |
| Relative Risk (RR) | Uncontrolled temporal association | 1.02 (95% CI: 0.95 - 1.09) | Null difference from unexposed cohort |
| Confounding Control | Zero adjustment for baseline age/health | Multivariable propensity score matching | Eliminates reporting & selection bias |
| Diagnostic Verification | Self-reported or unconfirmed notes | Independent clinical chart adjudication | Gold-standard phenotypic validation |
Epidemiological Sources & Literature Foundations:
- Madsen KM, et al. A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism. N Engl J Med. 2002. (Sample: 537,303 children).
- Hviid A, et al. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Ann Intern Med. 2019. (Sample: 657,461 children).
- CDC / FDA Vaccine Adverse Event Reporting System (VAERS) User Guide: Spontaneous reports represent temporal associations, not causality.